Glucagon-Like Peptide-1 Receptor/agonists

Pradhan, R. ., Lu, S. ., Yin, H. ., H. Y. Yu, O. ., Ernst, P. ., Suissa, S. ., & Azoulay, L. . (2022). Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study. Bmj, 379, e071380. http://doi.org/10.1136/bmj-2022-071380
Brunetti, V. C., St-Jean, A. ., Dell’Aniello, S. ., Fisher, A. ., H. Y. Yu, O. ., Bugden, S. C., … Filion, K. B. (2022). Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom. BMC Endocr Disord, 22, 241. http://doi.org/10.1186/s12902-022-01140-1